Viewing Study NCT04586673



Ignite Creation Date: 2024-05-06 @ 3:18 PM
Last Modification Date: 2024-10-26 @ 1:46 PM
Study NCT ID: NCT04586673
Status: COMPLETED
Last Update Posted: 2022-08-11
First Post: 2020-10-01

Brief Title: A Study to Assess Safety and Immunogenicity of Conserved Mosaic HIV-1 Vaccines
Sponsor: University of Oxford
Organization: University of Oxford

Study Overview

Official Title: A Phase I Dose Escalation Open Label Trial to Assess Safety and Immunogenicity of Candidate ChAdOx1- and MVA- Vectored Conserved Mosaic HIV-1 Vaccines Given Sequentially to Healthy HIV-1 Negative Adult Volunteers in Oxford UK
Status: COMPLETED
Status Verified Date: 2023-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The object of the study is to assess the safety profile of candidate vaccines ChAdOx1tHIVconsv1 MVAtHIVconsv3 and MVAtHIVcnsv4 administered sequentially in healthy HIV-12 negative adult volunteers

In addition the study will assess the immune responses generated of the candidate vaccines ChAdOx1tHIVconsv1 MVtHIVconsv3 and MVAtHIVconsv4 administered sequentially in healthy HIV-12 negative adult volunteers

3 healthy HIV-1 negative adult volunteers will receive one vaccination of low dose ChAdOx1tHIVconsv1 A further 10 healthy HIV-1 negative adult volunteers will receive a higher dose of ChAdOx1tHIVconsv1 followed by one vaccination each of MVAtHIVconsv3 and MVAtHIVconsv4 4 weeks later
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None